Skip to content
PeptideHound

Protocols

Semax protocols in the published literature

StatusNot FDA approved

PeptideHound Staff · Last editorially reviewed · 14 sources

Semax carries more human dosing detail than most compounds covered on this site, and nearly all of it comes from Russian clinical research that no study among these sources has repeated outside Russia. One stroke study states a regimen outright. The rest of the human work records a route and a concentration without ever stating a quantity.

The clearest figure comes from a 2018 rehabilitation study of 110 patients after ischemic stroke. Standard regimen of semax included 2 courses (6000 mcg/day) for 10 days with 20 day interval. That is a trial protocol in one specific condition, reported here as exactly that and nothing more.

The brain-imaging work used a different form entirely. Resting state fMRI was carried out 3 times: directly before and 5 and 20 min after intranasal 1% Semax (14 subjects) or placebo (10 subjects). A 1% solution is a concentration rather than an amount, and neither imaging paper states how much liquid reached a nostril. The animal figures are per kilogram and span two orders of magnitude, from doses of 5, 50, 150, and 450 μg/kg in one rat study up to 500 microg/kg in another.

None of that is a label. A 2000 Russian ophthalmology paper calls the compound a new Russian drug, and a 2026 review that searched FDA and WADA records reports that non-approved peptides showed promising preclinical and limited clinical evidence but lack long-term safety data and systematic validation. The same review lists optimal dosing regimens among the significant knowledge gaps it found.

Evidence: Not dosing guidance · one Russian stroke study reports a 6,000 mcg per day regimen in 110 patients · two brain-imaging studies used a single intranasal 1% solution · animal figures run from 5 to 500 micrograms per kilogram by two routes · much of the literature is Russian-language

What is the dosing protocol for Semax?

human pilot / early trial

One published protocol states a quantity, a frequency and a duration together, and it belongs to a single condition. A 2018 Russian study enrolled one hundred and ten patients after ischemic stroke, with a mean age of 58. Standard regimen of semax included 2 courses (6000 mcg/day) for 10 days with 20 day interval.7 So that is six thousand micrograms a day, ten days on, twenty days off, then ten days again. Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels in those patients, BDNF being a protein involved in the survival and growth of nerve cells.7 Read the word standard carefully, because it describes the arm of that investigation rather than a schedule anyone established. A 2026 review that searched regulatory databases lists optimal dosing regimens among the significant knowledge gaps it identified across this class of compounds.14 A protocol run once in stroke rehabilitation is a documented experiment, not a general schedule.

What does Semax nasal dosage mean, and what is 1%?

human pilot / early trial

The nasal figure people quote is a concentration, and a concentration is only half of an amount. A 2018 imaging study in healthy volunteers describes its administration precisely. Resting state fMRI was carried out 3 times: directly before and 5 and 20 min after intranasal 1% Semax (14 subjects) or placebo (10 subjects).8 One per cent means ten milligrams of peptide in every millilitre of liquid. What the paper does not record is how many drops went in, so the quantity each volunteer received cannot be worked out from it. A second study of 52 healthy participants reports the same gap, describing resting-state fMRI carried out before, after 5 and 20 min of the injection of either Semax, or Selank, or placebo.9 Earlier Russian eye work used the route without a figure as well: in group 1 semax was administered intransally as nasal drops, in group 2 by endonasal electrophoresis, and group 3 was control.1 Three human studies, one route, and no stated volume between them.

What amounts were used in the animal studies?

animal model

Four rat studies carry figures, and between them they span a hundredfold range in three different units. The widest test used intraperitoneal administration ACTH(4-7)-PGP in doses of 5, 50, 150, and 450 μg/kg to Wistar male rats.10 Intraperitoneal means into the belly, and a behaviour study used the nose instead. Semax was injected intranasally in doses of 50 and 500 microg/kg 15 min before the testing.5 A 2006 brain study stayed at the low end, where a single application of Semax (50 microg/kg body weight) gave a maximal 1.4-fold increase of BDNF protein levels in the rat hippocampus.4 The fourth changes the unit. Stressed and control male adult Sprague-Dawley rats received daily intraperitoneal injections of saline or a low dose (60 nmol/kg of body weight (BW)) of Semax.12 Nanomoles per kilogram count molecules rather than mass, so that figure cannot be set beside the others until somebody converts it.

Rat amounts from the four animal studies described above. Animal amounts, not converted to people and not a guide.
Rat studyRouteAmount studied (per kg, rats)
ACTH(4-7)-PGP dose-range studyInto the belly5, 50, 150 and 450 μg/kg
Behaviour studyInto the nose, 15 min before testing50 and 500 μg/kg
2006 brain studySingle application50 μg/kg
Stress study (Sprague-Dawley rats)Into the belly, daily60 nmol/kg, a count of molecules rather than mass

Is there a Semax dosage chart?

human pilot / early trial

Not a published one, and the reason is visible in the units rather than hidden in the literature. The human stroke work is written in micrograms per day. The imaging work is written as a percentage concentration. The rat work is written in micrograms per kilogram, except for the study that uses nanomoles per kilogram. A chart requires one axis that every row shares, and this literature does not provide one. The single experiment that does read like a chart is a rat study testing doses of 5, 50, 150, and 450 μg/kg before a stress model, which is a dose-response design rather than a schedule for anybody.10 A 2026 review searching FDA and WADA records lists optimal dosing regimens among the significant knowledge gaps it identified.14 The published total is one stated human regimen, in one condition, from one country, and a chart built on that is mostly invention.7

What is a Semax cycle, and how long is one?

human pilot / early trial

One published course has a defined shape, and three others are single administrations or short runs attached to an experiment. The defined one is the stroke regimen. Standard regimen of semax included 2 courses (6000 mcg/day) for 10 days with 20 day interval, which is the only on and off pattern in the published human record.7 Twenty days without material, between two ten-day courses, is a specific design decision and the paper does not explain why that interval was chosen. The animal courses are shorter and simpler. A gastric study in albino rats used postoperative treatment with Semax for 5 days after an injury was induced.2 A hippocampal study used a single application of Semax (50 microg/kg body weight) and read the result from one administration.4 None of those durations was compared against an alternative, so the literature contains examples of cycles rather than evidence about them.

What does the literature show about a Semax injection dose?

human pilot / early trial

Every injected figure on record comes from a rat. The split between routes runs straight down the middle of this subject. The injected work is animal, and it goes into the belly. Semax administered intraperitoneally in a dose of 50 microg/kg one hour before exposure to ulcerogenic factors protected gastric mucosa from damage in albino rats.2 A 2024 depression model gave rats daily intraperitoneal injections of a low dose (60 nmol/kg of body weight (BW)).12 A 2024 gene study used the same route, with rats receiving intraperitoneal administration of ACTH-like peptides ACTH(4-7)PGP (Semax).11 The human work went up the nose. The imaging volunteers received intranasal 1% Semax, and the Russian eye studies used nasal drops or a small electric current.8 No study among the research behind this page has given Semax to a person by a shot under the skin. So an injected human figure crosses both a species gap and a route gap, rather than resting on anything measured.

What is known about N-Acetyl Semax Amidate?

in vitro

Almost nothing about amounts. The one paper that bears on it is laboratory chemistry, not a protocol. A 2016 study looked at what acetylation does to the molecule. N-terminal amino group acetylation (Ac-Semax) modulates the chemical and biological properties of parental peptide, modifying the ability of Semax to form complex species with Cu(II) ion.6 In plain terms, the altered version binds copper differently. The practical finding runs the other way: Semax acetylation did not protect from Cu(II) induced toxicity on a SH-SY5Y neuroblastoma cell line, a human nerve-cell line grown in a dish.6 That is a result from glassware. No study among the research behind this page attaches an amount, a route or a schedule to an acetylated or amidated form. So a figure quoted for that version is not a bigger or smaller Semax figure. It is a number for a molecule that no paper we cite has dosed in print, rather than a scaled copy of anything above.

How much bacteriostatic water do you mix with Semax?

human pilot / early trial

That depends entirely on the concentration being aimed at, and the published record supplies exactly one concentration to aim at. The imaging studies used intranasal 1% Semax.8 One per cent means one gram in a hundred millilitres, which works out at ten milligrams in every millilitre. So a vial holding 30 mg of dry material would need 3 mL of liquid to reach that concentration, and a vial holding 10 mg would need 1 mL. The arithmetic is the same in either direction: divide the quantity of material by the volume of water to get the concentration. What that calculation produces is a concentration matching one published study, and nothing more. It does not establish how much liquid should then be used, and the imaging papers never recorded that figure either. Matching a concentration from a study and matching what the study administered are separate things, and only the first is available here.

How do percent, mg and mcg relate on a label?

human pilot / early trial

Three ways of writing the same quantity turn up on this compound, and they are easy to confuse because two of them describe concentration and one describes an amount. A percentage describes concentration. Intranasal 1% Semax is ten milligrams of peptide in each millilitre of liquid, and that figure says nothing about how much liquid is involved.8 Milligrams per millilitre describe the same thing in different words, so 1% and 10 mg/mL are interchangeable labels. Micrograms describe an amount of peptide, with no liquid implied. The stroke regimen of 6000 mcg/day is six milligrams of peptide a day, because one milligram is a thousand micrograms.7 Converting between the two columns requires a volume, and that is the number missing from most of the published work on this compound.

How was Semax administered in the studies?

human pilot / early trial

Four routes appear across the literature, and the human and animal work barely overlap. The human studies used the nose. Russian eye work split its patients by delivery: one group was administered intransally as nasal drops, a second by endonasal electrophoresis.1 That second method drives material through tissue with a small electric current. The imaging studies used intranasal 1% Semax and gave no further detail.8 The rat work mostly used a shot into the belly, as in the study giving doses of 5, 50, 150, and 450 μg/kg to Wistar male rats.10 A 2005 review raises a fourth option, noting that the ability of glyprolines to pass gastro-enteric tract barriers opens ways to per-oral administration of this new group of drugs such as semax, selank and their fragments.3 That is a point about stability in the gut, not a swallowed protocol anybody has run.

Why the animal per-kilogram figures do not convert

animal model

Because three separate things would have to be assumed at once, and no published work supports any of them for this compound. The first is species. Every per-kilogram figure here was set for a rat and read against a rat endpoint, including the behavioural study where Semax was injected intranasally in doses of 50 and 500 microg/kg.5 The second is the unit, because a 2024 study expresses its figure as 60 nmol/kg of body weight (BW), counting molecules rather than mass, and converting between the two needs the molecular weight rather than a ratio.12 The third is the shape of the experiments. A rat study testing doses of 5, 50, 150, and 450 μg/kg was mapping a curve, not identifying a working figure, and a curve mapped in rats does not locate a point for anybody else.10 This page publishes no conversion from any of those figures to a human amount, and nothing among the research behind this page has validated one.

How much does Semax cost?

human pilot / early trial

No source among the research behind this page records a price, and the figure that would actually drive one is the length of a course rather than the price of a vial. The only published human course is the stroke regimen: 2 courses (6000 mcg/day) for 10 days with 20 day interval.7 Six milligrams a day across twenty dosing days is a hundred and twenty milligrams of peptide, which is a quantity a reader can at least compare against a vial size. Nothing among the research behind this page establishes that any shorter or longer course does anything. So the honest position on cost is that the denominator is missing. A 2026 review searching regulatory databases lists optimal dosing regimens among the significant knowledge gaps across this class of compounds, and a price per milligram means little when the number of milligrams anybody should buy has not been established in a published trial.14

Why do the reported protocols vary so much?

human pilot / early trial

Four reasons, and the language of the literature is the one most readers never see. Most of the clinical work is Russian and published in Russian journals, including the 2000 ophthalmology paper describing a new Russian drug semax.1 A reader outside that literature sees fragments of it in translation, which is part of why the figures circulating in English have no consistent source behind them. The second reason is the endpoint, which ranges from stroke rehabilitation to optic nerve disease to resting brain imaging in healthy volunteers. The third is the form, because the acetylated version studied in 2016 is chemically a different molecule from the Semax in the clinical papers.6 The fourth is the state of the evidence overall. A 2026 orthopaedic review covering semax among other neuroactive peptides concludes that although preclinical studies are promising, there is a current lack of clinical trials, and a 2026 gerontology review lists optimal dosing regimens among its significant knowledge gaps.1314

What we don’t know

The gaps in the evidence matter as much as the findings.

  1. 01What amount suits anything other than stroke rehabilitation. The one stated human regimen was run in patients recovering from ischemic stroke, and no trial among the research behind this page has tested it for anything else.
  2. 02How much liquid a 1% intranasal administration actually delivered. Both imaging studies report the concentration and not the volume, so the quantity each volunteer received is not on the public record.
  3. 03Whether the injected animal figures mean anything for a person. All of the per-kilogram work was done in rats, most of it by injection into the abdominal cavity, and no human study has used that route.
  4. 04What N-Acetyl Semax Amidate does at any amount. The only published work on an acetylated form is laboratory chemistry on metal binding, with no animal or human protocol attached.
  5. 05What a cycle length should be. The 10-day course with a 20-day interval was a study design in one condition, and no trial among the research behind this page has compared it against any other schedule.
  6. 06Whether anything happens past two courses. The stroke study stopped there, and nothing among the research behind this page follows a longer exposure.
  7. 07What the Russian label says. No label text appears in the published literature, so the regimen above is a trial protocol rather than an approved schedule.
  8. 08What a vial sold outside that supply contains. No analysis among the research behind this page has measured the identity or concentration of material sold under this name.

Sources

  1. 1[Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease] Vestn Oftalmol 2000. PMID 10741256human pilot / early trial
  2. 2Effect of Semax on homeostasis of gastric mucosa in albino rats Bull Exp Biol Med 2000. PMID 11177268animal model
  3. 3Natural and hybrid ("chimeric") stable regulatory glyproline peptides Pathophysiology 2005. doi:10.1016/j.pathophys.2004.10.001animal model
  4. 4Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus Brain Res 2006. doi:10.1016/j.brainres.2006.07.108animal model
  5. 5[Influence of Semax on the emotional state of white rats in the norm and against the background of cholecystokinin-tetrapeptide action] Izv Akad Nauk Ser Biol 2010. PMID 20387390animal model
  6. 6Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties J Inorg Biochem 2016. doi:10.1016/j.jinorgbio.2016.08.013in vitro
  7. 7[The efficacy of semax in the tretament of patients at different stages of ischemic stroke] Zh Nevrol Psikhiatr Im S S Korsakova 2018. doi:10.17116/jnevro20181183261-68human pilot / early trial
  8. 8Effects of Semax on the Default Mode Network of the Brain Bull Exp Biol Med 2018. doi:10.1007/s10517-018-4234-3human pilot / early trial
  9. 9Functional Connectomic Approach to Studying Selank and Semax Effects Dokl Biol Sci 2020. doi:10.1134/S001249662001007Xhuman pilot / early trial
  10. 10Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH((4-7))-PGP (Semax) Bull Exp Biol Med 2021. doi:10.1007/s10517-021-05072-zanimal model
  11. 11Changes of Transcriptomic Activity in Rat Brain Cells under the Influence of Synthetic Adrenocorticotropic Hormone-Like Peptides Biochemistry (Mosc) 2024. doi:10.1134/S0006297924090104animal model
  12. 12Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress Eur J Pharmacol 2024. doi:10.1016/j.ejphar.2024.177068animal model
  13. 13Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions J Am Acad Orthop Surg Glob Res Rev 2026. doi:10.5435/JAAOSGlobal-D-25-00236review
  14. 14Therapeutic peptides in gerontology: mechanisms and applications for healthy aging Front Aging 2026. doi:10.3389/fragi.2026.1790247review